CELC
Price
$72.10
Change
-$3.03 (-4.03%)
Updated
Oct 2 closing price
Capitalization
3.9B
47 days until earnings call
Intraday BUY SELL Signals
TMED
Price
$33.22
Change
-$0.12 (-0.36%)
Updated
Oct 2 closing price
Net Assets
33.03M
Intraday BUY SELL Signals
Interact to see
Advertisement

CELC vs TMED

CELC vs TMED Comparison Chart in %
View a ticker or compare two or three
VS
CELC vs. TMED commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Hold and TMED is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
55
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELCTMED
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 11 days ago
90%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 2 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
28%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (CELC: $75.13)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green while .

  • CELC’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 4 TA indicator(s) are bullish.

  • CELC’s TA Score: 4 bullish, 4 bearish.

Price Growth

CELC (@Biotechnology) experienced а -5.34% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

CELC is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CELC
Daily Signal:
Gain/Loss:
TMED
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IDGT113.511.08
+0.96%
iShares U.S. Digital Infrastructure and Real Estate ETF (IDGT)
WEEL19.900.09
+0.45%
Peerless Option Income Wheel ETF (WEEL)
ZFEB26.36-0.01
-0.06%
Innovator 1 Yr February (ZFEB)
FLTR25.51-0.08
-0.31%
VanEck IG Floating Rate ETF (FLTR)
SMUP3.10-0.09
-2.82%
T-REX 2X Long SMR Daily Target ETF (SMUP)

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been closely correlated with IMA. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CELC jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-5.52%
IMA - CELC
76%
Closely correlated
+0.22%
SLXN - CELC
50%
Loosely correlated
+0.61%
IMVT - CELC
41%
Loosely correlated
-0.38%
IMTX - CELC
41%
Loosely correlated
-3.87%
ANRO - CELC
41%
Loosely correlated
-0.86%
More

TMED and

Correlation & Price change

A.I.dvisor tells us that TMED and BNTX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TMED and BNTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMED
1D Price
Change %
TMED100%
-1.78%
BNTX - TMED
27%
Poorly correlated
-1.48%
CELC - TMED
19%
Poorly correlated
-5.52%
PCVX - TMED
18%
Poorly correlated
-1.49%
ALNY - TMED
17%
Poorly correlated
-6.31%
ISRG - TMED
17%
Poorly correlated
-1.33%
More